Results 71 to 80 of about 295,380 (280)

Primary follicular lymphoma of the small intestine

, 2004
While nodal follicular lymphoma is prevalent in western countries, primary extranodal presentation is rare. We present the clinico-pathological and radiologic features of a patient with primary follicular lymphoma of the small intestine presenting with ...
Leung, AY, Chim, CS, Tsang, J, Loong, F, Ooi, GC   +4 more
core   +1 more source

Risk of Bias Associated with Varying Sampling Strategies for External Comparator Cohorts for Single‐Arm Trials: Insights from Aggressive Lymphoma

Clinical Pharmacology &Therapeutics, EarlyView.
Marketing authorizations for oncology drugs are often based on single‐arm trials (SATs), and real‐world data‐based external comparator cohorts (ECCs) are increasingly explored to contextualize results. In retrospective studies, comparators may be identified by time of diagnosis but included based on time of relapse; such sampling strategies can ...
Mikkel Runason Simonsen, Shiva Leisner, Ahmed Ludvigsen Al‐Mashhadi, Laurids Østergaard Poulsen, Matthew Maurer, Lasse Hjort Jakobsen, Tarec Christoffer El‐Galaly   +6 more
wiley   +1 more source

Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity

Indian Journal of Pathology and Microbiology
Plasmablastic transformation of follicular lymphoma is very rare and has been reported in only 5 cases till date. We report a case of simultaneous identification of extranodal, soft tissue plasmablastic lymphoma in the ankle and bone marrow involvement ...
Shanaz Khodaiji, Vidisha Mahajan, Krishna Sawaimoon Satyakam, Pratibha Sudhan Kadam Amare   +3 more
doaj   +1 more source

Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Accurate quantification of chimeric antigen receptor (CAR) T cells is essential for monitoring post‐infusion CART expansion and persistence and for real‐time clinical decision‐making. Multiparameter flow cytometry (MFC) enables rapid, live‐cell detection with absolute quantification and concurrent immunophenotypic characterization. This review
Jianhua Ling, Wei Wang, Sa A. Wang
wiley   +1 more source

Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients

, 2007
BACKGROUND: It is unclear whether new treatment modalities have improved the survival of follicular lymphoma patients. Some data show that there has been no improvement in survival in the last 3 decades of the 20th century, whereas the results of recent ...
D. Vallisa, S. Sacchi, F. Merli, S. Luminari, F. Angrilli, L. Baldini, S. Pozzi, M. Brugiatelli, L. Marcheselli, A. Bari, Italian lymphoma study group   +10 more
core   +1 more source

The broad landscape of follicular lymphoma: Part II

, 2020
Follicular lymphoma is a neoplasm derived from follicle center B cells, typically both centrocytes and centroblasts, in variable proportions according to the lymphoma grading.
Sanguedolce, Francesca, Filosa, Alessandra, Zanelli, Magda, Martino, Giovanni, Soriano, Alessandra, Fratoni, Stefano, Aimola, Valentina, Cerrone, Giulia, Ricci, Linda, Ascani, Stefano, Fara, Antonella Maria, Annessi, Valerio, Zizzo, Maurizio   +12 more
core   +1 more source

Harmonizing flow‐based quantification of CD19‐directed CAR‐T cells: Results from a multi‐center interlaboratory comparison

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract CD19‐directed CAR‐T cell therapy has become the standard of care for the treatment of relapsed/refractory LBCL, MCL, FL and BCP‐ALL. Expansion of CAR‐T cells in the peripheral blood (PB) of patients in the first weeks after infusion is an important biomarker for the prediction of therapy response and occurrence of toxicities.
Gerulf Hänel, Veit Bücklein, Carolina Berger, Anita Badbaran, Boris Fehse, Guranda Chitadze, Deniz Nogueira Gezer, Michael Hundemer, Wolfgang Kern, Sarah Klapproth, Ines Peschel‐Schaar, Christiane Siewert, Simon Völkl, Maria Xydia, Thomas Nebe, Michael Spannagl, Marion Subklewe   +16 more
wiley   +1 more source

Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab

, 2023
Paolo Lopedote,1 Mazyar Shadman2,3 1Department of Medicine, St Elizabeth’s Medical Center, Boston, MA, USA; 2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; 3Department of Medicine, University of Washington, Seattle, WA ...
Shadman M, Lopedote P
core  

Clinical, Radiologic and Cytologic Predictors of Malignancy in Pediatric Thyroid Nodules: Insights From a 26‐Year Cohort Study

Head &Neck, EarlyView.
ABSTRACT Introduction Thyroid nodules are less common but more often malignant in pediatric patients than in adults. Our objectives were to study the features of benign vs. malignant thyroid nodules in a large pediatric patient cohort. Methods Retrospective observational cohort study. Consecutive patients aged 0.01–17.9 years at evaluation between 1997–
Maxime Gest‐Laurent, Adrien Nguyen Quoc, Christine Lefevre, Laura González‐Briceño, Caroline Thalassinos, Isabelle Flechtner, Dulanjalee Kariyawasam, Yamina Dassa, Magali Viaud, Dinane Samara‐Boustani, Graziella Pinto, Hervé Monpeyssen, Sabine Sarnacki, Vincent Couloigner, Michel Polak, Athanasia Stoupa   +15 more
wiley   +1 more source

Controversies in the Treatment of Follicular Lymphoma

HemaSphere, 2020
. The overall prognosis of patients with follicular lymphoma has substantially improved over the last decades with a 10-year overall survival of around 80% for the majority of patients.
Kai Hübel, Michele Ghielmini, Marco Ladetto, Ajay K. Gopal   +3 more
doaj   +1 more source